Results per Page:
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
The exclusion of immunocompromised patients in clinical trials and how we can do better
From Drs. Michael Boeckh, Joshua Hill, Steven Pergam and Larry Corey, Hematologic Malignancies and Cancer Immunology Programs of the Cancer Consortium
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
CMV breakthrough and resistance to antiviral drug after blood stem cell transplants
From Dr. Danniel Zamora and the Boeckh Group, Vaccine and Infectious Disease Division
Antibiotics with anaerobic activity: an anti-hero against viruses
From the Boeckh Lab, Vaccine and Infectious Disease Division
Naïve and memory T cells elicit a convergent response to CMV
From the Boeckh, Bradley, and Prlic Labs, a collaboration between the Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions
From the freezers, a speedier way to evaluate antiviral drugs
Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
New study will track workers at high risk for coronavirus
Volunteers to provide regular samples to help close knowledge gaps in how COVID-19 spreads undetected
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Predicting lower respiratory disease in transplant patients
From the Boeckh lab, Vaccine and Infectious Disease Division
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award
Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
Physician assistant Debra Mattson to retire May 24
She has been the historian — and the heart —of the Infectious Disease Consult Service
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments
Dr. Steve Pergam receives Dr. Ali Al-Johani Award
An expert in infection prevention who is also a 'passionate patient care advocate and an outstanding physician'
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Good News: Stemming the harm common virus causes in critically ill patients
Celebrating faculty and staff achievements
Good News: Fred Hutch scientists to develop bioassay for ovarian cancer for new NCI initiative
Celebrating faculty and staff achievements